Perrigo: Funding, Investors & Team (Sep 2026)
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.
Perrigo has raised $2.6B across 1 funding round on record, the most recent a Post-IPO Debt of $2.6B announced in Apr 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Perrigo Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Perrigo Funding Rounds
Perrigo Founders and Leadership Team
Contact details for the Perrigo team: 1 of 1 has an email address on file.
Start 14-day free trial →Perrigo Funding Compared to Other Biotechnology Startups
Perrigo's latest round of $2.6B is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Perrigo in Biotechnology and Dublin
Companies Similar to Perrigo
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Antler Bio employs gene expression data to assist in herd management and provides services for analyzing…
Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling…
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the…
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Relevium Medical is a biopharmaceutical company with offices in both Ireland and the US that aims to enhance…
Ovagen Group Limited is a veterinary company based out of Ballina, Mayo, Ireland.
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed…
Beyondbmi offers specialized doctors and nutritionists who focus on managing weight, as well as the most…
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara…
Medical device company developing a closure device for vascular access procedures.
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target…
Perrigo Funding FAQs
What does Perrigo do?
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.
How much funding has Perrigo raised?
Perrigo has raised $2.6B across 1 round on record. The most recent is a Post-IPO Debt of $2.6B announced in Apr 2022.
When did Perrigo last raise funding?
Perrigo's most recent funding round on record is a Post-IPO Debt of $2.6B, announced in Apr 2022.
Who is the CEO of Perrigo?
Murray Kessler is listed as CEO at Perrigo.
Where is Perrigo headquartered?
Perrigo is based in Dublin, Ireland.
How many employees does Perrigo have?
Perrigo is in the 10001+ employee band.
How does Perrigo's funding compare to other Biotechnology startups?
Perrigo's latest round of $2.6B is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Perrigo Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Perrigo is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.